Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000141

EVP Research and Development gave up 304 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

STAHL NEIL · EVP Research and Development

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-16 Shares withheld for taxes : show line 1 in the form −304 $730.81 $222,166 48,829 D
Loading xslF345X05/edgardoc.xml…